NSEGeneral Updates22h ago · 24 Sept 2026, 07:45 pm

General Updates

Themis Medicare Limited · THEMISMED

✦ AI SummaryFundraise

Themis Medicare Limited has withdrawn its proposed preferential issue of 45,95,795 convertible equity warrants, citing a need to consider a fresh issue in the future to meet the company's working capital requirements.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Themis Medicare Limited has informed the Exchange about the Withdrawal of proposed Preferential Issue of 45,95,795 convertible equity warrants.

Attachments (1)

📄

THEMISMED_24092026194457_Reg30withdrawalntimationTML.pdf

pdf

Download →
View document text
TML/BSE/NSE/2026-27/27 24th September, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code – 530199 Bandra (East), Mumbai- 400051 Symbol: THEMISMED Sub.: Withdrawal of proposed Preferential Issue of 45,95,795 convertible equity warrants. Dear Sir / Madam, We refer to our intimation dated February 25, 2026 informing approval by the Preferential Issue Committee of the Board for proposal to issue of warrants convertible into equity shares to the promoters group entity by way of preferential issue of 45,95,795 warrants at a price of Rs. 102.87 per warrant (the Issue) and further intimation dated March 10, 2026 in this respect. We further update you that it decided today to withdraw the proposed Issue. The reasons for withdrawing the Issue include with a view to consider fresh issue in future with such objects as may be necessary or to meet requirement of the Company in future as and when necessary. The objective of the Issue was mainly to strengthen working capital requirement of the Company, which now have been arranged and met by way of other means. The Company has made application for an in-principal approval for the above proposed Issue to BSE Limited (BSE) and National Stock Exchange of India Limited (NSE). The Company will withdraw the said applications. Accordingly, all disclosures / intimations / submissions including made to the Stock Exchanges in connection with this preferential issue be treated as withdrawn. We hereby clarify and assure you that the withdrawal of the above-mentioned proposed Issue shall not have any adverse impact on the financial position and operations of the Company. Thanking you Yours faithfully For Themis Medicare Limited Dr. Sachin Patel Managing Director DIN: 00033273 Themis Medicare Limited Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India *Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621 Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219 *E-mail: themis@themismedicare.com*Website: www.themismedicare.com